Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/325219 
Autor:innen: 
Erscheinungsjahr: 
2025
Quellenangabe: 
[Journal:] Finance and Society [ISSN:] 2059-5999 [Publisher:] Cambridge University Press [Place:] Cambridge [Year:] 2025 [Pages:] 1-23
Verlag: 
Cambridge University Press, Cambridge
Zusammenfassung: 
This article traces the shifting fortunes of for-profit psychedelic medicine through two phases: a boom from 2016 to late 2021, followed by a bust that continued through late 2024. It argues that the forces driving this cycle are best understood through the concept of capitalization, which links present valuations to investor expectations about future earnings. Engaging the capital-as-power framework, the article situates psychedelic companies within the broader biopharmaceutical sector, showing how the volatility of drug development is intensified by the unruliness of these substances as capitalized assets. This unruliness stems from a range of factors, including murky intellectual property claims, unpredictable and intense subjective experiences, and lingering cultural stigma. During the boom, firms attracted significant interest from venture capital and other investors by promising revolutionary breakthroughs in mental health treatment. As expectations rose, so did valuations. But disappointing results from clinical trials, regulatory setbacks, and deepening doubts about the ability to control and standardize psychedelic therapies led to sharp declines in investor confidence. Analyzing financial performance alongside investor narratives, the article underscores the tensions involved in subjecting these unruly substances to the logic of capitalist power.
Schlagwörter: 
capitalization
capital as power
differential accumulation
finance
hype
mental health
pharmaceutical
profit
psychedelics
JEL: 
P1
P12
P14
I11
L65
D3
G3
I14
Persistent Identifier der Erstveröffentlichung: 
URL der Erstveröffentlichung: 
Creative-Commons-Lizenz: 
cc-by-nc-nd Logo
Dokumentart: 
Article
Dokumentversion: 
Published Version

Datei(en):
Datei
Größe





Publikationen in EconStor sind urheberrechtlich geschützt.